Log in to save to my catalogue

It’s good to know what to BACE the specificity of your inhibitors on

It’s good to know what to BACE the specificity of your inhibitors on

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11324289

It’s good to know what to BACE the specificity of your inhibitors on

About this item

Full title

It’s good to know what to BACE the specificity of your inhibitors on

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2024-08, Vol.134 (16), p.1-4

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Production, aggregation, and clearance of the amyloid β peptide (Aβ) are important processes governing the initial pathogenesis of Alzheimer's disease (AD). Inhibition of β-site amyloid precursor protein (APP) cleaving enzyme (BACE1) (one of two key proteases responsible for Aβ production) as an AD-therapeutic approach so far has failed to yield a...

Alternative Titles

Full title

It’s good to know what to BACE the specificity of your inhibitors on

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11324289

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11324289

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI183677

How to access this item